Ras, but not Src, transformation of RIE-1 epithelial cells is dependent on activation of the mitogen-activated protein kinase cascade
- PMID: 9632133
- DOI: 10.1038/sj.onc.1201784
Ras, but not Src, transformation of RIE-1 epithelial cells is dependent on activation of the mitogen-activated protein kinase cascade
Abstract
Src transformation of NIH3T3 mouse fibroblasts has been shown to be dependent on Ras function. Since we recently showed that the signaling pathways that mediate Ras transformation of RIE-1 rat intestinal epithelial cells are distinct from those that cause Ras transformation of fibroblasts, we utilized three approaches to determine if Src transformation of RIE-1 cells is dependent on Ras. First, although both Ras and Src cause upregulation of an epidermal growth factor (EGF) receptor-dependent autocrine growth loop, only Ras transformation required this activity. Second, whereas both Src and Ras caused upregulation of the p42 and p44 mitogen-activated protein kinases (MAPKs), only Ras transformation was blocked by the inhibition of MAPK activation by treatment with the PD 98059 MEK inhibitor. Third, treatment with the farnesyltransferase inhibitor FTI-277 blocked Ras, but not Src, transformation. Taken together, these observations suggest that Src transformation of RIE-1 cells is not dependent on Ras. Finally, we determined that Ras activation of Raf-independent pathways alone is sufficient to cause growth transformation of RIE-1 cells. Thus, both Ras and Src cause transformation of RIE-1 cells via pathways distinct from those required to cause transformation of NIH3T3 cells.
Similar articles
-
Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.Mol Cancer Res. 2004 Apr;2(4):233-41. Mol Cancer Res. 2004. PMID: 15140945
-
Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways.Cancer Res. 2002 Jul 15;62(14):4142-50. Cancer Res. 2002. PMID: 12124353
-
Ras-mediated intestinal epithelial cell transformation requires cyclooxygenase-2-induced prostaglandin E2 signaling.Mol Carcinog. 2007 Dec;46(12):958-70. doi: 10.1002/mc.20333. Mol Carcinog. 2007. PMID: 17477350
-
Ras farnesyltransferase: a new therapeutic target.J Med Chem. 1997 Sep 12;40(19):2971-90. doi: 10.1021/jm970226l. J Med Chem. 1997. PMID: 9301658 Review. No abstract available.
-
In vitro transformation of epithelial cells by ras oncogenes.Epithelial Cell Biol. 1993 Jan;2(1):26-43. Epithelial Cell Biol. 1993. PMID: 8353592 Review.
Cited by
-
Dominant negative inhibitors of signalling through the phosphoinositol 3-kinase pathway for gene therapy of pancreatic cancer.Gut. 2005 Jan;54(1):109-16. doi: 10.1136/gut.2004.046706. Gut. 2005. PMID: 15591514 Free PMC article.
-
Pro-neoplastic effects of amphiregulin in colorectal carcinogenesis.J Gastrointest Cancer. 2013 Jun;44(2):211-21. doi: 10.1007/s12029-012-9474-2. J Gastrointest Cancer. 2013. PMID: 23263765
-
Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase.Mol Cell Biol. 2001 Aug;21(16):5488-99. doi: 10.1128/MCB.21.16.5488-5499.2001. Mol Cell Biol. 2001. PMID: 11463831 Free PMC article.
-
Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin.Mol Cell Biol. 2002 Apr;22(7):2304-17. doi: 10.1128/MCB.22.7.2304-2317.2002. Mol Cell Biol. 2002. PMID: 11884615 Free PMC article.
-
Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells.Am J Pathol. 2000 Dec;157(6):1937-45. doi: 10.1016/s0002-9440(10)64832-8. Am J Pathol. 2000. PMID: 11106566 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous